Medicare Enrolled

Dr. John Hajjar, MD

Urology Physician · Jersey City, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
176 PALISADE AVE STE 3E, Jersey City, NJ 07306
2014352244
In practice since 2006 (20 years)
NPI: 1104894435 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hajjar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hajjar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hajjar

Dr. John Hajjar is an urology physician in Jersey City, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hajjar performed 2,715 Medicare services across 1,572 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hajjar received a total of $8,539 from 21 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hajjar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 2,715 Medicare services $8,539 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,715
Medicare services
Bottom 48% in NJ for urology physician
1,572
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~136 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
690 $72 $292
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
685 $3 $14
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
191 $10 $37
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
163 $116 $486
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
156 $89 $372
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $100 $420
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
114 $8 $30
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
109 $93 $384
Leuprolide acetate (for depot suspension), 7.5 mg 106 $134 $728
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
90 $77 $304
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
76 $119 $551
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
55 $12 $48
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
49 $81 $369
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
33 $31 $117
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
25 $170 $2,773
CT scan of pelvis with and without contrast
A CT scan of the pelvis performed using both intravenous contrast dye and without it to provide detailed images of internal structures.
17 $47 $863
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
14 $56 $836
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
12 $92 $830
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
12 $22 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,539
Total received (2018-2024)
Avg $1,220/year across 7 years
Top 16% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$4,470 (52.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,140 (36.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$929 (10.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,208
2023
$4,166
2022
$295
2021
$14
2020
$1,973
2019
$117
2018
$765

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$859
Sumitomo Pharma America, Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$74
Janssen Biotech, Inc.
$72
Axonics, Inc.
$64
Tolmar, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$15
Antares Pharma, Inc.
$14
Top 3 companies account for 84.8% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$4,560
Allergan, Inc.
$1,960
Abbott Laboratories
$600
Astellas Pharma US Inc
$329
Sumitomo Pharma America, Inc.
$184
Bayer Healthcare Pharmaceuticals Inc.
$156
Antares Pharma, Inc.
$122
AstraZeneca Pharmaceuticals LP
$117
Smith & Nephew, Inc.
$116
Axonics, Inc.
$93
Janssen Biotech, Inc.
$72
Ambu Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$40
Supernus Pharmaceuticals, Inc.
$32
Acerus Pharmaceuticals Corporation
$26
Tolmar, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$15
Teleflex LLC
$14
Endo Pharmaceuticals Inc.
$14
NeoTract Inc.
$13
ABBVIE INC.
$13
Top 3 companies account for 83.4% of all-time payments
Associated products mentioned in payments ›
ALLODERM · AVEED · Axonics · ELIGARD · ERLEADA · EVIS EXERA · EVIS EXERA lll COLONOVIDEOSCOPE · FARXIGA · GEMTESA · JYNARQUE · LENS Surgical Imaging System · LUPRON DEPOT · Myrbetriq · NOCDURNA · Natesto · Nubeqa · Olympus · TLANDO · UroLift · UroLift System · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Looking for an urology physician in Jersey City?
Compare urology physicians in the Jersey City area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
712
Per 100K population
100.2
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-CHRIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hajjar is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 16% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hajjar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Hajjar performed 690 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hajjar receive payments from pharmaceutical companies?
Yes. Dr. Hajjar received a total of $8,539 from 21 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hajjar's costs compare to other urology physicians in Jersey City?
Dr. Hajjar's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hajjar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →